Dantron

Dantron
Clinical data
Routes of; administration	Oral, rectal (enema)
ATC code	A06AB03 (WHO) A06AG03 (WHO);
Identifiers
	IUPAC name 1,8-dihydroxyanthracene-9,10-dione;
CAS Number	117-10-2 ;
PubChem CID	2950;
DrugBank	DB04816 ;
ChemSpider	2845 ;
UNII	Z4XE6IBF3V;
KEGG	D07107 ;
ChEBI	CHEBI:3682 ;
ChEMBL	ChEMBL53418 ;
NIAID ChemDB	001375;
CompTox Dashboard (EPA)	DTXSID9020328 ;
ECHA InfoCard	100.003.794
Chemical and physical data
Formula	C14H8O4
Molar mass	240.214 g·mol−1
3D model (JSmol)	Interactive image;
Density	1.575 g/cm3 g/cm3
	SMILES O=C2c1cccc(O)c1C(=O)c3c2cccc3O;
	InChI InChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H ; Key:QBPFLULOKWLNNW-UHFFFAOYSA-N ;
	(what is this?) (verify)

Dantron (INN), also known as chrysazin or 1,8-dihydroxyanthraquinone, is an orange-colored organic substance. Many structurally-related compounds are known. In terms of its molecular structure, it is related anthraquinone by the replacement of two hydrogen atoms by hydroxyl groups (–OH). It is used in some countries as a stimulant laxative.

It should not be confused with ondansetron, an unrelated drug that was marketed in South Africa under the trade name "Dantron".

Clinical data


Routes of administration	Oral, rectal (enema)
ATC code	A06AB03 (WHO) A06AG03 (WHO)
Identifiers
IUPAC name 1,8-dihydroxyanthracene-9,10-dione
CAS Number	117-10-2^Y
PubChem CID	2950
DrugBank	DB04816^N
ChemSpider	2845^Y
UNII	Z4XE6IBF3V
KEGG	D07107^N
ChEBI	CHEBI:3682^N
ChEMBL	ChEMBL53418^N
NIAID ChemDB	001375
CompTox Dashboard (EPA)	DTXSID9020328
ECHA InfoCard	100.003.794
Chemical and physical data
Formula	C₁₄H₈O₄
Molar mass	240.214 g·mol⁻¹
3D model (JSmol)	Interactive image
Density	1.575 g/cm³ g/cm³
SMILES O=C2c1cccc(O)c1C(=O)c3c2cccc3O
InChI InChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H^N Key:QBPFLULOKWLNNW-UHFFFAOYSA-N^N
^NY (what is this?) (verify)